Harvard Bioscience, Inc. (HBIO)
NASDAQ · Healthcare
Harvard Bioscience, Inc. Long Term Debt 2009–2025
Harvard Bioscience, Inc. annual long term debt history from 2010 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Harvard Bioscience, Inc. long term debt as of December 31, 2025: 35.9M, a 2.94% decrease year-over-year.
- Harvard Bioscience, Inc. long term debt for 2025 were 35.9M, a 2.94% decrease from 2024.
- Harvard Bioscience, Inc. long term debt for 2024 were 37.0M, a 0.00% increase from 2023.
- Harvard Bioscience, Inc. long term debt for 2023 were 37.0M, a 21.07% decrease from 2022.
- Harvard Bioscience, Inc. long term debt for 2022 were 46.8M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Harvard Bioscience, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $36 |
| 2024 | $37 |
| 2023 | $37 |
| 2022 | $47 |
| 2021 | $48 |
| 2020 | $48 |
| 2019 | $54 |
| 2018 | $61 |
| 2017 | $12 |
| 2016 | $14 |
| 2015 | $19 |
| 2014 | $21 |
| 2013 | $25 |
| 2012 | $13 |
| 2011 | $16 |
Harvard Bioscience, Inc. Long Term Debt — FAQ
Harvard Bioscience, Inc. (HBIO) long term debt over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see HBIO's long term debt history?
The chart and table above show Harvard Bioscience, Inc.'s long term debt by year and by quarter, including the growth rate.